Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted ...
Analyses of self-tests for human papillomavirus (HPV) can be used to divide HPV-positive women into three risk groups, according to a new study. This method could be important for enhancing cervical ...
Learn about the importance of colorectal cancer screening, especially for African Americans, as one woman shares her personal ...
Prostate cancer screening plans could be scaled back even further, despite growing calls for more testing to be rolled out.
The survey results reveal strong enthusiasm for blood-based screening options among adults aged 45 and older, the group ...
A landmark trial aiming to shape the future of prostate cancer screening in the UK has begun testing a group of men considered to be at the highest risk of developing the disease. The Transform trial, ...
This is the second in a 2-part series focused on quality improvement in cancer screening. The first part highlighted screening specific to breast and colon cancer. This part will review theories of ...
In a randomized trial of prostate cancer screening methods, a blood-based diagnostic test and MRI with subsequent targeted plus systematic prostate biopsies outperformed the standard approach of ...
The ‘90s sitcom “Full House” documented many of the ups and downs of growing up, including the often-excruciating experience ...
Colorectal cancer is the third most common cancer in men and women and the second leading cause of cancer deaths in the U.S., ...
A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The Transform trial, a collaborative effort funded by Prostate Cancer UK and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results